Atlas Trials

Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

Clinical trial NCT06635330 · RECRUITING

Trial details

NCT number
NCT06635330
Sponsor
Kara Yakhteh Tajhiz Azma Company
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapse/Refractory B-cell Acute Lymphoblastic Leukemia
Start date
2024-05-20
Primary completion
2026-09-22
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.